Japan Insider Activity (EDINET) — 2026-09-08

by japan-insider-activities-daily

🇯🇵 EDINET DB Report — 2026-09-08

🔁 BUYBACK — 6191 Airtrip (ToSTNeT-3 off-auction purchase — result & completion) Read: Airtrip has wrapped up its ToSTNeT-3 off-market share buyback, confirming the repurchase is finished, though no total size is disclosed in this notice.

🔁 BUYBACK — 9561 Gladcube (monthly buyback progress) Read: Gladcube filed a routine monthly update on its ongoing share buyback program; no total size given here.

🔁 BUYBACK — 9882 Yellow Hat (monthly buyback progress) Read: Yellow Hat filed a routine monthly progress update on its ongoing share buyback; no total size given here.

🔁 BUYBACK — 4078 Sakai Chemical Industry (buyback progress & completion) Read: Sakai Chemical has completed the share buyback authorized under its articles of incorporation, a management-confidence signal, though no total size is disclosed here.

🔁 BUYBACK — 7441 Misumi (monthly buyback progress) Read: Misumi filed a routine monthly update on its ongoing share buyback; no total size given here.

🔁 BUYBACK — 9603 H.I.S. (monthly buyback progress) Read: H.I.S. filed a routine monthly progress update on its ongoing share buyback program; no total size given here.

🔁 BUYBACK — 8766 Tokio Marine Holdings (monthly buyback progress) Read: Tokio Marine Holdings filed a routine monthly update on its ongoing share buyback; no total size given here.

🔁 BUYBACK — 9475 Shobunsha Holdings (monthly buyback progress) Read: Shobunsha Holdings filed a routine monthly progress update on its ongoing share buyback; no total size given here.

🔁 BUYBACK — 7476 AS ONE (self-tender offer — result, completion & major shareholder change) Read: AS ONE has completed a tender-offer-style buyback of its own shares, closing the program and triggering a change in major shareholders — a stronger-than-usual confidence signal, though size isn't given in this notice.

🔁 BUYBACK — 6381 Anest Iwata (buyback progress & completion) Read: Anest Iwata has completed its share buyback program, a management-confidence signal, though no total size is disclosed here.

🔁 BUYBACK — 2588 Premium Water Holdings (monthly buyback progress) Read: Premium Water Holdings filed a routine monthly update on its ongoing share buyback; no total size given here.

🔁 BUYBACK — 7318 Serendip Holdings (buyback progress & completion) Read: Serendip Holdings has completed its share buyback program; no total size is disclosed in this notice.

🔁 BUYBACK — 6841 Yokogawa Electric (correction to prior buyback completion notice) Read: Yokogawa Electric issued a correction to its earlier buyback-completion announcement; the underlying signal — an articles-authorized repurchase wrapping up — stands, with no figures disclosed here.

🎯 TOB — 7475 Albis ← Life Corporation (8194), launch Read: Life Corporation has launched a tender offer for Albis at ¥3,780/share (51.1% premium), open 2026-09-09–2026-11-10, consolidating the supermarket sector. Source: https://finance.biggo.jp/news/jpx_tdnet_140120260908533017

🎯 TOB — 7475 Albis ← Life Corporation (8194), opinion Read: Albis's board has formally endorsed Life Corporation's ¥3,780/share tender offer (51.2% premium) and is recommending shareholders tender, offer period 2026-09-09–2026-11-10. Source: https://www.lifecorp.jp/vc-files/pdf/ir/news/20260908.pdf

🎯 TOB — 4477 BASE ← SBI Holdings via SBINM GK (8473), amendment Read: SBI Holdings' subsidiary SBINM GK has amended the terms of its ¥340/share tender offer (9.32% premium) for BASE, Inc., offer period 2026-08-31–2026-09-30. Source: https://www.release.tdnet.info/inbs/140120260908533089.pdf

📈 GUIDANCE UP — 3083 Starseeds (full-year earnings forecast raised) Read: Starseeds raised its FY Feb 2027 consolidated earnings forecast, signaling the business is tracking ahead of prior guidance.

📈 GUIDANCE UP — 1436 Green Energy & Company (earnings forecast raised) Read: Green Energy & Company raised its earnings forecast, pointing to stronger-than-expected results versus prior guidance.

📊 GUIDANCE REVISED — 4880 Cellsource (earnings forecast revised, direction unclear — see filing) Read: Cellsource revised its earnings forecast, but the title doesn't state the direction, so check the filing to see whether it's an upgrade or downgrade.

📊 GUIDANCE REVISED — 7475 Albis (H1 & full-year forecasts revised, direction unclear — see filing) Read: Albis revised both its H1 and full-year (FY March 2027) consolidated earnings forecasts with no stated direction — notable timing since the stock is simultaneously the target of Life Corporation's tender offer above.